Article Details
Retrieved on: 2018-03-06 19:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Millennium Management LLC now owns 113,300 shares of the biopharmaceutical company's stock worth $419,000 after purchasing an additional 51,000 shares during the last quarter. <b>Two Sigma Investments</b> LP acquired a new position in Cascadian Therapeutics in the 4th quarter valued at $181,000.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here